VERU

1.9408.06%
MS

Mitchell S. Steiner

Chairman, President & CEO

Dr. Mitchell S. Steiner, also known as Mitch, M.D., F.A.C.S, has been the Chief Executive Officer, President and Director at Veru Inc. (formerly known as The Female Health Company) since October 31, 2016 & has been its Chairman from March 2018. Dr. Steiner Co-Founded Aspen Park Pharmaceuticals, Inc. and served as its Chief Executive Officer and President. Dr. Steiner Co-founded GTx Inc. in September 1997 and served as its Vice Chairman and Chief Executive Officer from September 1997 to April 3, 2014. He had been Member of Board of Advisors at arGentis Pharmaceuticals, LLC since August 2010. He serves as a Member of Financial Advisory Board at MB Venture Partners and MB Venture, LLC. Dr. Steiner served numerous Academic appointments, including Chairman and Professor of Urology, Director of Urologic Oncology and Research and the Chair of Excellence in Urologic Oncology at the University of Tennessee from 1995 to 2004. Dr. Steiner simultaneously had an appointment as Assistant Professor of Urology, Cell Biology and Pathology while at Vanderbilt University School of Medicine from 1993 to 1995. He served as Vice Chairman of Aspen Park Pharmaceuticals, Inc. since July 2014 until October 2016 and served as its Director. From 2014 to 2016, Dr. Steiner was a consultant and then the President of Urology and Member of senior management of OPKO Health, Inc. He conducted gene therapy clinical trials for prostate cancer in which he has served as a consultant and Principal Investigator. Dr. Steiner has conducted independent laboratory research in cancer since 1980 and has been the recipient of grants from the National Institutes of Health and the Department of Defense. Dr. Steiner has authored more than 200 abstracts and publications and he serves on the Editorial Board of several peer reviewed medical publications in the fields of urology and oncology. Dr. Steiner is Board Certified in Urology (February 1997) and a Fellow of the American College of Surgeons (October 2000). Dr. Steiner holds a B.A. in Molecular Biology and Chemistry from Vanderbilt University and an M.D. from the University of Tennessee in 1986. He obtained a Molecular Biology Postdoctoral fellowship as an American Foundation for Urologic Disease Scholar from Vanderbilt University from 1986 to 1995. He performed his surgical and urologic training at The Johns Hopkins Hospital and postdoctoral research fellow in cell biology at Vanderbilt School of Medicine.

Positions